ZA200710497B - Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders - Google Patents
Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disordersInfo
- Publication number
- ZA200710497B ZA200710497B ZA200710497A ZA200710497A ZA200710497B ZA 200710497 B ZA200710497 B ZA 200710497B ZA 200710497 A ZA200710497 A ZA 200710497A ZA 200710497 A ZA200710497 A ZA 200710497A ZA 200710497 B ZA200710497 B ZA 200710497B
- Authority
- ZA
- South Africa
- Prior art keywords
- glepp
- autoimmune
- treatment
- inhibitors
- inflammatory disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05106547 | 2005-07-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200710497B true ZA200710497B (en) | 2009-04-29 |
Family
ID=35423337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200710497A ZA200710497B (en) | 2005-07-15 | 2006-07-14 | Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20080207722A1 (sr) |
| EP (1) | EP1904048B1 (sr) |
| JP (1) | JP2009501197A (sr) |
| KR (1) | KR20080036084A (sr) |
| CN (1) | CN101282719A (sr) |
| AT (1) | ATE534380T1 (sr) |
| AU (1) | AU2006271682B2 (sr) |
| BR (1) | BRPI0613400A2 (sr) |
| CA (1) | CA2609929A1 (sr) |
| CY (1) | CY1112148T1 (sr) |
| DK (1) | DK1904048T3 (sr) |
| EA (1) | EA200800342A1 (sr) |
| ES (1) | ES2377881T3 (sr) |
| HR (1) | HRP20110875T1 (sr) |
| IL (1) | IL188735A (sr) |
| MX (1) | MX2008000665A (sr) |
| NO (1) | NO20080781L (sr) |
| PL (1) | PL1904048T3 (sr) |
| PT (1) | PT1904048E (sr) |
| RS (1) | RS52116B (sr) |
| SI (1) | SI1904048T1 (sr) |
| UA (1) | UA94049C2 (sr) |
| WO (1) | WO2007009959A1 (sr) |
| ZA (1) | ZA200710497B (sr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME02414B (me) * | 2009-07-30 | 2016-09-20 | Teva Pharma | Tretman kronove bolesti lakvinimodom |
| US9493436B2 (en) * | 2011-04-26 | 2016-11-15 | Indiana University Research And Technology Corporation | Tyrosine phosphatase inhibitors and uses thereof to modulate the activity of enzymes involved in the pathology of Mycobacterium tuberculosis |
| JP2019504828A (ja) * | 2015-12-22 | 2019-02-21 | シンジェンタ パーティシペーションズ アーゲー | 殺微生物性オキサジアゾール誘導体 |
| CN107936110B (zh) * | 2017-11-07 | 2021-06-22 | 潍坊医学院 | 突变基因Nasp在狼疮性模型小鼠自身免疫病发病中的作用及机制 |
| EP4132523A4 (en) * | 2020-04-06 | 2024-05-15 | Purdue Research Foundation | Novel n-aryl oxamic acids |
| CA3247765A1 (en) * | 2022-01-27 | 2025-07-10 | Vivozon,Inc. | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF A MENTAL DISORDER |
| CN118239851B (zh) * | 2024-03-20 | 2025-07-25 | 蚌埠医科大学 | 一种ptpro抑制剂的制备方法及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE82916B1 (en) | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
| EP0727406B1 (de) * | 1995-02-16 | 2001-09-05 | MERCK PATENT GmbH | Vinylenverbindungen und flüssigkristallines Medium |
| AU5347496A (en) * | 1995-04-21 | 1996-11-07 | Daiichi Pharmaceutical Co., Ltd. | Ethynylthiazole derivative |
| FR2762514B1 (fr) * | 1997-04-29 | 1999-10-22 | Sanofi Sa | Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation |
| BR0213233A (pt) | 2001-10-12 | 2005-01-04 | Warner Lambert Co | Alcinos inibidores de metaloproteinase de matriz |
| US7696231B2 (en) * | 2001-10-30 | 2010-04-13 | Laboratoires Serono Sa | Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs) |
| JP2003171305A (ja) * | 2001-11-30 | 2003-06-20 | Yunie:Kk | 糖尿病改善治療剤 |
| JP2005170790A (ja) | 2002-01-09 | 2005-06-30 | Ajinomoto Co Inc | N−アルキルスルフォニル置換アミド誘導体 |
| CN100410236C (zh) * | 2002-01-29 | 2008-08-13 | 雪兰诺实验室有限公司 | 作为蛋白酪氨酸磷酸酶调节剂的取代亚甲基酰胺衍生物 |
| EP1603858A2 (en) * | 2003-03-11 | 2005-12-14 | NeuroSearch A/S | Kcnq channel modulating compounds and their pharmaceutical use |
| EP1654247B1 (en) * | 2003-07-21 | 2010-01-20 | Merck Serono SA | Alkynyl aryl carboxamides |
| WO2005007616A1 (en) | 2003-07-23 | 2005-01-27 | Warner-Lambert Company Llc | Diphenylamino ketone derivatives as mek inhibitors |
| BRPI0508790A (pt) * | 2004-04-07 | 2007-09-04 | Applied Research Systems | ácido carboxìlicos, uso de um ácido carboxìlico, composto farmacêutico, método de preparação de ácido carboxìlico e composto intermediário |
-
2006
- 2006-07-14 PT PT06777795T patent/PT1904048E/pt unknown
- 2006-07-14 AT AT06777795T patent/ATE534380T1/de active
- 2006-07-14 US US11/916,097 patent/US20080207722A1/en not_active Abandoned
- 2006-07-14 ZA ZA200710497A patent/ZA200710497B/xx unknown
- 2006-07-14 CA CA002609929A patent/CA2609929A1/en not_active Abandoned
- 2006-07-14 DK DK06777795.3T patent/DK1904048T3/da active
- 2006-07-14 UA UAA200800236A patent/UA94049C2/ru unknown
- 2006-07-14 RS RS20110580A patent/RS52116B/sr unknown
- 2006-07-14 EA EA200800342A patent/EA200800342A1/ru unknown
- 2006-07-14 HR HR20110875T patent/HRP20110875T1/hr unknown
- 2006-07-14 AU AU2006271682A patent/AU2006271682B2/en not_active Expired - Fee Related
- 2006-07-14 JP JP2008520891A patent/JP2009501197A/ja active Pending
- 2006-07-14 BR BRPI0613400-9A patent/BRPI0613400A2/pt not_active IP Right Cessation
- 2006-07-14 CN CNA2006800336726A patent/CN101282719A/zh active Pending
- 2006-07-14 MX MX2008000665A patent/MX2008000665A/es active IP Right Grant
- 2006-07-14 ES ES06777795T patent/ES2377881T3/es active Active
- 2006-07-14 KR KR1020087003525A patent/KR20080036084A/ko not_active Ceased
- 2006-07-14 EP EP06777795A patent/EP1904048B1/en active Active
- 2006-07-14 PL PL06777795T patent/PL1904048T3/pl unknown
- 2006-07-14 WO PCT/EP2006/064288 patent/WO2007009959A1/en not_active Ceased
- 2006-07-14 SI SI200631196T patent/SI1904048T1/sl unknown
-
2008
- 2008-01-13 IL IL188735A patent/IL188735A/en not_active IP Right Cessation
- 2008-02-13 NO NO20080781A patent/NO20080781L/no not_active Application Discontinuation
-
2011
- 2011-12-14 CY CY20111101240T patent/CY1112148T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20110875T1 (hr) | 2011-12-31 |
| IL188735A0 (en) | 2008-12-29 |
| BRPI0613400A2 (pt) | 2011-01-11 |
| EP1904048A1 (en) | 2008-04-02 |
| US20080207722A1 (en) | 2008-08-28 |
| JP2009501197A (ja) | 2009-01-15 |
| CY1112148T1 (el) | 2015-11-04 |
| AU2006271682B2 (en) | 2012-07-05 |
| PL1904048T3 (pl) | 2012-04-30 |
| UA94049C2 (ru) | 2011-04-11 |
| DK1904048T3 (da) | 2011-12-19 |
| SI1904048T1 (sl) | 2012-01-31 |
| RS52116B (sr) | 2012-08-31 |
| CA2609929A1 (en) | 2007-01-25 |
| KR20080036084A (ko) | 2008-04-24 |
| CN101282719A (zh) | 2008-10-08 |
| ES2377881T3 (es) | 2012-04-02 |
| AU2006271682A1 (en) | 2007-01-25 |
| WO2007009959A1 (en) | 2007-01-25 |
| EA200800342A1 (ru) | 2008-08-29 |
| MX2008000665A (es) | 2008-03-13 |
| ATE534380T1 (de) | 2011-12-15 |
| NO20080781L (no) | 2008-02-13 |
| PT1904048E (pt) | 2011-12-19 |
| IL188735A (en) | 2012-07-31 |
| EP1904048B1 (en) | 2011-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2009000381A1 (en) | C5 antigens and uses thereof | |
| NO20072558L (no) | Mitotiske kineseinhibitorer og fremgangsmater for anvendelse derav | |
| IL197080A0 (en) | Pyrimidone compounds as gsk-3 inhibitors | |
| MX2010002732A (es) | Inhibidores de f1f0-atpasa y metodos relacionados. | |
| IL190201A0 (en) | Pde inhibitors and combinations thereof for the treatment of urological disorders | |
| MX2010008397A (es) | Inhibidores del receptor de quimioquinas cxcr3. | |
| IL219644A0 (en) | Kinase inhibitors and methods of use thereof | |
| MX2009004757A (es) | Moduladores de regeneracion neuronal. | |
| IL188735A0 (en) | Use of glepp-1 inhibitor for the menufacture of a medicament for treament of an autoimmune and/or inflamatory disorder | |
| TW200716153A (en) | Mitotic kinesin inhibitors and methods of use thereof | |
| IL193943A0 (en) | The use of beta- aminoalcohols for the treatment of inflammatory disorders and pain | |
| ATE489947T1 (de) | Axomadol zur schmerzbehandlung bei arthrose | |
| WO2006124477A3 (en) | Combination therapy with inhibitors of hmgb and caspase for the treatment of inflammatory diseases | |
| TW200642688A (en) | New use of PDE7 inhibitors | |
| UA96736C2 (ru) | Ингибиторы pi3k для лечения эндометриоза | |
| IL193944A0 (en) | The use beta-aminoalcohols for the treatment of inflammatory disorders and pain | |
| ATE552888T1 (de) | Elastasehemmer bei leukämie | |
| MX2009004296A (es) | Inhibidores de canal ih para promover insomnio. | |
| SG165343A1 (en) | Jnk inhibitors for the treatment of endometriosis | |
| TN2010000369A1 (en) | Inhibitors of the chemokine receptor cxcr3 | |
| HK1120217A (en) | The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain | |
| GB0609794D0 (en) | The treatment of inflammatory disorders and pain |